Stay updated on Safety of SNA-120 in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.

Latest updates to the Safety of SNA-120 in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedA new page revision tag, v3.5.4, was added and the previous tag v3.5.3 removed, indicating a newer build of the page. This appears to be a small maintenance update rather than a content or feature change.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a new page version. This update reflects metadata changes rather than substantive content changes.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page behavior.SummaryDifference0.0%

- Check59 days agoChange DetectedA new Revision: v3.5.0 was added and the previous Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded Revision: v3.4.2. Removed the notice about government funding and the earlier Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Safety of SNA-120 in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.